Cardiovascular Drugs and Therapy View Homepage


Ontology type: schema:Periodical     


Journal Info

START YEAR

1987

PUBLISHER

Springer US

LANGUAGE

en

HOMEPAGE

http://link.springer.com/journal/10557

Recent publications latest 20 shown

  • 2019-04-06 HFREF Patients and Atrial Fibrillation: Time to Reconsider the Appropriateness of the Atrial Fibrillation Ablation in This Patient Subset?
  • 2019-03-23 “Real World” Eligibility for Sacubitril/Valsartan in Unselected Heart Failure Patients: Data from the Swedish Heart Failure Registry
  • 2019-03-23 AST-120, an Adsorbent of Uremic Toxins, Improves the Pathophysiology of Heart Failure in Conscious Dogs
  • 2019-03-20 Special Issue: British Society for Cardiovascular Research
  • 2019-03-19 Health Economic Analysis of Rivaroxaban and Warfarin for Venous Thromboembolism Management in Chinese Patients
  • 2019-03-18 Activation of T Lymphocytes as a Novel Mechanism in Beta1-Adrenergic Receptor Autoantibody-Induced Cardiac Remodeling—Additional Information About TLR9 Involvement
  • 2019-03-12 Medical Misinformation: Vet the Message!
  • 2019-03-09 Effects of Teneligliptin on the Progressive Left Ventricular Diastolic Dysfunction in Patients with Type 2 Diabetes Mellitus in Open-Label, Marker-Stratified Randomized, Parallel-Group Comparison, Standard Treatment-Controlled Multicenter Trial (TOPLEVEL Study): Rationale and Study Design
  • 2019-03-07 The Role of Thyroid Hormones in Heart Failure
  • 2019-03-02 Combination Therapy of Pulmonary Arterial Hypertension with Vardenafil and Macitentan Assessed in a Human Ex Vivo Model
  • 2019-03-02 Examining the Risks of Major Bleeding Events in Older People Using Antithrombotics
  • 2019-02-28 Sacubitril/Valsartan in Real-Life Practice: Experience in Patients with Advanced Heart Failure and Systematic Review
  • 2019-02-26 GATA4-Twist1 Signalling in Disturbed Flow-Induced Atherosclerosis
  • 2019-02-19 Platelet MicroRNA 365-3p Expression Correlates with High On-treatment Platelet Reactivity in Coronary Artery Disease Patients
  • 2019-02-18 HDL-Targeted Therapies During Myocardial Infarction
  • 2019-02-18 Association of Elevated Plasma Homocysteine Level with Restenosis and Clinical Outcomes After Percutaneous Coronary Interventions: a Systemic Review and Meta-analysis
  • 2019-02-12 Improved Long-term Survival with Remote Limb Ischemic Preconditioning in a Rat Fixed-Pressure Hemorrhagic Shock Model
  • 2019-02-12 Emerging Roles of Sympathetic Nerves and Inflammation in Perivascular Adipose Tissue
  • 2019-02-12 Activation of T Lymphocytes as a Novel Mechanism in Beta1-Adrenergic Receptor Autoantibody-Induced Cardiac Remodeling
  • 2019-02-11 Characteristics and Cardiovascular Disease Event Rates among African Americans and Whites Who Meet the Further Cardiovascular Outcomes Research with PCSK9 Inhibition in Subjects with Elevated Risk (FOURIER) Trial Inclusion Criteria
  • Subjects

    JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "about": [
          {
            "id": "http://scigraph.springernature.com/ontologies/product-market-codes/H33037", 
            "inDefinedTermSet": "http://scigraph.springernature.com/ontologies/product-market-codes/", 
            "name": "Cardiology", 
            "type": "DefinedTerm"
          }
        ], 
        "contentRating": [
          {
            "author": "snip", 
            "ratingValue": "0.808", 
            "type": "Rating"
          }, 
          {
            "author": "sjr", 
            "ratingValue": "1.349", 
            "type": "Rating"
          }, 
          {
            "author": "impact_factor_wos", 
            "dateCreated": "2017", 
            "ratingValue": "2.771", 
            "type": "Rating"
          }, 
          {
            "author": "impact_factor_wos", 
            "dateCreated": "2016", 
            "ratingValue": "2.820", 
            "type": "Rating"
          }, 
          {
            "author": "impact_factor_wos", 
            "dateCreated": "2016", 
            "ratingValue": "2.820", 
            "type": "Rating"
          }, 
          {
            "author": "impact_factor_wos", 
            "dateCreated": "2015", 
            "ratingValue": "3.189", 
            "type": "Rating"
          }, 
          {
            "author": "impact_factor_wos", 
            "dateCreated": "2015", 
            "ratingValue": "3.189", 
            "type": "Rating"
          }, 
          {
            "author": "impact_factor_wos", 
            "dateCreated": "2014", 
            "ratingValue": "3.189", 
            "type": "Rating"
          }, 
          {
            "author": "impact_factor_wos", 
            "dateCreated": "2014", 
            "ratingValue": "3.189", 
            "type": "Rating"
          }, 
          {
            "author": "impact_factor_wos", 
            "dateCreated": "2013", 
            "ratingValue": "2.952", 
            "type": "Rating"
          }, 
          {
            "author": "impact_factor_wos", 
            "dateCreated": "2013", 
            "ratingValue": "2.952", 
            "type": "Rating"
          }, 
          {
            "author": "impact_factor_wos", 
            "dateCreated": "2010", 
            "ratingValue": "3.098", 
            "type": "Rating"
          }, 
          {
            "author": "impact_factor_wos", 
            "dateCreated": "2009", 
            "ratingValue": "2.515", 
            "type": "Rating"
          }, 
          {
            "author": "impact_factor_wos", 
            "dateCreated": "2009", 
            "ratingValue": "2.515", 
            "type": "Rating"
          }, 
          {
            "author": "impact_factor_wos", 
            "dateCreated": "2012", 
            "ratingValue": "2.673", 
            "type": "Rating"
          }, 
          {
            "author": "impact_factor_wos", 
            "dateCreated": "2012", 
            "ratingValue": "2.673", 
            "type": "Rating"
          }, 
          {
            "author": "impact_factor_wos", 
            "dateCreated": "2011", 
            "ratingValue": "3.130", 
            "type": "Rating"
          }, 
          {
            "author": "impact_factor_wos", 
            "dateCreated": "2011", 
            "ratingValue": "3.130", 
            "type": "Rating"
          }, 
          {
            "author": "impact_factor_wos", 
            "dateCreated": "2010", 
            "ratingValue": "3.098", 
            "type": "Rating"
          }
        ], 
        "description": "

    Designed to objectively cover the process of bench to bedside development of cardiovascular drug, device and cell therapy, and to bring you the information you need most in a timely and useful format, Cardiovascular Drugs and Therapy takes a fresh and energetic look at advances in this dynamic field.

    Homing in on the most exciting work being done on new therapeutic agents, Cardiovascular Drugs and Therapy focusses on developments in atherosclerosis, hyperlipidemia, diabetes, ischemic syndromes and arrhythmias. The Journal is an authoritative source of current and relevant information that is indispensable for basic and clinical investigators aiming for novel, breakthrough research as well as for cardiologists seeking to best serve their patients.

    Providing you with a single, concise reference tool acknowledged to be among the finest in the world, Cardiovascular Drugs and Therapy is listed in Web of Science and PubMed/Medline among other abstracting and indexing services. The regular articles and frequent special topical issues equip you with an up-to-date source defined by the need for accurate information on an ever-evolving field. Cardiovascular Drugs and Therapy is a careful and accurate guide through the maze of new products and therapies which furnishes you with the details on cardiovascular pharmacology that you will refer to time and time again.

    Five\u00a0Reasons to Publish Your Article in Cardiovascular Drugs and Therapy:

    \u00b7 High usage: Articles frequently downloaded from month to month

    \u00b7 Wide distribution: Institutions worldwide having full text access

    \u00b7 Efficient handling: 18 days between submission and first decision

    \u00b7 Fast publication:\u00a017 days between acceptance and online publication

    \u00b7 International readership: North America, Asia, Europe, Middle East and South America

    ", "editor": [ { "familyName": "Remme", "givenName": "Willem J.", "type": "Person" } ], "id": "sg:journal.1097576", "inLanguage": [ "en" ], "isAccessibleForFree": false, "issn": [ "0920-3206", "1573-7241" ], "license": "Hybrid (Open Choice)", "name": "Cardiovascular Drugs and Therapy", "productId": [ { "name": "scopus_id", "type": "PropertyValue", "value": [ "22552" ] }, { "name": "wos_id", "type": "PropertyValue", "value": [ "0920-3206/CARDIOVASCULAR DRUGS AND THERAPY" ] }, { "name": "nlm_unique_id", "type": "PropertyValue", "value": [ "8712220" ] }, { "name": "nsd_ids_id", "type": "PropertyValue", "value": [ "339953" ] }, { "name": "springer_id", "type": "PropertyValue", "value": [ "10557" ] }, { "name": "lccn_id", "type": "PropertyValue", "value": [ "89646567" ] }, { "name": "dimensions_id", "type": "PropertyValue", "value": [ "97576" ] }, { "name": "era_ids_id", "type": "PropertyValue", "value": [ "14709" ] } ], "publisher": { "name": "Springer US", "type": "Organization" }, "publisherImprint": "Springer", "sameAs": [ "https://app.dimensions.ai/discover/publication?and_facet_source_title=jour.1097576" ], "sdDataset": "journals", "sdDatePublished": "2019-03-18T11:05", "sdLicense": "https://scigraph.springernature.com/explorer/license/", "sdPublisher": { "name": "Springer Nature - SN SciGraph project", "type": "Organization" }, "sdSource": "file:///home/ubuntu/piotr/scigraph_export/journals_20190313_sn_only.jsonl", "startYear": "1987", "type": "Periodical", "url": "http://link.springer.com/journal/10557" } ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/journal.1097576'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/journal.1097576'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/journal.1097576'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/journal.1097576'


     

    This table displays all metadata directly associated to this object as RDF triples.

    195 TRIPLES      21 PREDICATES      48 URIs      43 LITERALS      30 BLANK NODES

    Subject Predicate Object
    1 sg:journal.1097576 schema:about sg:ontologies/product-market-codes/H33037
    2 schema:contentRating N0679d2ad59764948aee0e731024955d2
    3 N1524f3d599be4f069c58dfedd8e70839
    4 N198feb7cc2824b7c8bef845010bc7024
    5 N27055a861d944f349e896ccd981d9029
    6 N27fe07329daf4fbfa67b9e802a75e441
    7 N53df1cd4f02f434988f4fbca7a441979
    8 N62a05b0c0e5a4b36b7f3b089fb41991c
    9 N64ad88ffca474ae4b76a2766f452dade
    10 N65e2023cf47442efb52ee9a7d15f1c2d
    11 N6fc64dee360b46cb87b589216e68955f
    12 N7b92e298bbed42f380381c11796cddf7
    13 N963510edcf164bf495d64fc5b0a457dd
    14 N9cbd216a61c54d12b140f2d030792e39
    15 Na54cf57933ab4737800f5f3bd537f341
    16 Nad6b482a7c8b4a4a90c3696b081abdaa
    17 Naf2096091a1e4b66a5286f81d7228547
    18 Nb05be21926a94ce5ae77ebe726dfbe81
    19 Nc1a0e052e4374b798d8c6dcae47cbc8f
    20 Ncf82eb3a41e548c8bb98034f02fb1224
    21 schema:description <p>Designed to objectively cover the process of bench to bedside development of cardiovascular drug, device and cell therapy, and to bring you the information you need most in a timely and useful format, <i>Cardiovascular Drugs and Therapy</i> takes a fresh and energetic look at advances in this dynamic field.</p><p>Homing in on the most exciting work being done on new therapeutic agents, <i>Cardiovascular Drugs and Therapy</i> focusses on developments in atherosclerosis, hyperlipidemia, diabetes, ischemic syndromes and arrhythmias. The Journal is an authoritative source of current and relevant information that is indispensable for basic and clinical investigators aiming for novel, breakthrough research as well as for cardiologists seeking to best serve their patients.</p><p>Providing you with a single, concise reference tool acknowledged to be among the finest in the world, <i>Cardiovascular Drugs and Therapy</i> is listed in Web of Science and PubMed/Medline among other abstracting and indexing services. The regular articles and frequent special topical issues equip you with an up-to-date source defined by the need for accurate information on an ever-evolving field. <i>Cardiovascular Drugs and Therapy</i> is a careful and accurate guide through the maze of new products and therapies which furnishes you with the details on cardiovascular pharmacology that you will refer to time and time again.</p><p><p/><p>Five Reasons to Publish Your Article in <i>Cardiovascular Drugs and Therapy</i>:</p><p>· High usage: Articles frequently downloaded from month to month</p><p>· Wide distribution: Institutions worldwide having full text access</p><p>· Efficient handling: 18 days between submission and first decision </p><p>· Fast publication: 17 days between acceptance and online publication</p><p>· International readership: North America, Asia, Europe, Middle East and South America </p><p/></p>
    22 schema:editor Nc9e24fa05114405c8474c1c0aa8df738
    23 schema:inLanguage en
    24 schema:isAccessibleForFree false
    25 schema:issn 0920-3206
    26 1573-7241
    27 schema:license Hybrid (Open Choice)
    28 schema:name Cardiovascular Drugs and Therapy
    29 schema:productId N0c671c1dd3b14fc9930a4db96442f0be
    30 N18ae22d9a3ca40838ebc17f592553182
    31 N1c24f1b3754142feba0afde6ecd49898
    32 N2a734013d60948a194b98002d2818b60
    33 N57b75eb74ff848a08b0e7210fe18ec7f
    34 N595710337ca94791b72a7097e121c355
    35 N8c51552e315142eab771f7c9de20fe14
    36 Nac664664617242748f05a670ef17b8b0
    37 schema:publisher N21c29cf247b3455d8fea95d93df3cae3
    38 schema:publisherImprint Springer
    39 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_source_title=jour.1097576
    40 schema:sdDatePublished 2019-03-18T11:05
    41 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    42 schema:sdPublisher N174570e0768d4c0e85f800d148ec4152
    43 schema:startYear 1987
    44 schema:url http://link.springer.com/journal/10557
    45 sgo:license sg:explorer/license/
    46 sgo:sdDataset journals
    47 rdf:type schema:Periodical
    48 N0679d2ad59764948aee0e731024955d2 schema:author N5b8171a16fc8442faa1991922aaedd26
    49 schema:dateCreated 2009
    50 schema:ratingValue 2.515
    51 rdf:type schema:Rating
    52 N0c671c1dd3b14fc9930a4db96442f0be schema:name wos_id
    53 schema:value 0920-3206/CARDIOVASCULAR DRUGS AND THERAPY
    54 rdf:type schema:PropertyValue
    55 N1524f3d599be4f069c58dfedd8e70839 schema:author Ncaf68e302f724bc0823303f7d6f3d09b
    56 schema:dateCreated 2012
    57 schema:ratingValue 2.673
    58 rdf:type schema:Rating
    59 N174570e0768d4c0e85f800d148ec4152 schema:name Springer Nature - SN SciGraph project
    60 rdf:type schema:Organization
    61 N18ae22d9a3ca40838ebc17f592553182 schema:name scopus_id
    62 schema:value 22552
    63 rdf:type schema:PropertyValue
    64 N198feb7cc2824b7c8bef845010bc7024 schema:author N8dc78b5d1207437fa0549d642d44d633
    65 schema:dateCreated 2016
    66 schema:ratingValue 2.820
    67 rdf:type schema:Rating
    68 N1c24f1b3754142feba0afde6ecd49898 schema:name era_ids_id
    69 schema:value 14709
    70 rdf:type schema:PropertyValue
    71 N21c29cf247b3455d8fea95d93df3cae3 schema:name Springer US
    72 rdf:type schema:Organization
    73 N27055a861d944f349e896ccd981d9029 schema:author N9d53a431086d4d66a515dbcb9e1f47bf
    74 schema:dateCreated 2011
    75 schema:ratingValue 3.130
    76 rdf:type schema:Rating
    77 N27b163b642a94145b16dd2b284026dc0 rdf:first impact_factor_wos
    78 rdf:rest rdf:nil
    79 N27fe07329daf4fbfa67b9e802a75e441 schema:author N9651b1385e554082ab3ae28749081f8b
    80 schema:dateCreated 2013
    81 schema:ratingValue 2.952
    82 rdf:type schema:Rating
    83 N2a734013d60948a194b98002d2818b60 schema:name nsd_ids_id
    84 schema:value 339953
    85 rdf:type schema:PropertyValue
    86 N361871e603c04d299c0aba024811a640 rdf:first impact_factor_wos
    87 rdf:rest rdf:nil
    88 N4603d7dba2a34b02803a9e7221b150b6 rdf:first impact_factor_wos
    89 rdf:rest rdf:nil
    90 N53df1cd4f02f434988f4fbca7a441979 schema:author N71dd4105fe374871962e2a3ec6b2235a
    91 schema:dateCreated 2016
    92 schema:ratingValue 2.820
    93 rdf:type schema:Rating
    94 N57b75eb74ff848a08b0e7210fe18ec7f schema:name dimensions_id
    95 schema:value 97576
    96 rdf:type schema:PropertyValue
    97 N595710337ca94791b72a7097e121c355 schema:name nlm_unique_id
    98 schema:value 8712220
    99 rdf:type schema:PropertyValue
    100 N5b8171a16fc8442faa1991922aaedd26 rdf:first impact_factor_wos
    101 rdf:rest rdf:nil
    102 N5d61925e03a740b1aeecf5791d49e645 rdf:first impact_factor_wos
    103 rdf:rest rdf:nil
    104 N62a05b0c0e5a4b36b7f3b089fb41991c schema:author N71ed2763f98942fd8f70d561f4d892ed
    105 schema:dateCreated 2011
    106 schema:ratingValue 3.130
    107 rdf:type schema:Rating
    108 N64ad88ffca474ae4b76a2766f452dade schema:author N4603d7dba2a34b02803a9e7221b150b6
    109 schema:dateCreated 2012
    110 schema:ratingValue 2.673
    111 rdf:type schema:Rating
    112 N65e2023cf47442efb52ee9a7d15f1c2d schema:author N27b163b642a94145b16dd2b284026dc0
    113 schema:dateCreated 2015
    114 schema:ratingValue 3.189
    115 rdf:type schema:Rating
    116 N663d64830088467f909b3928c855b336 rdf:first impact_factor_wos
    117 rdf:rest rdf:nil
    118 N6714ba7a4179429d9802072d976b6502 rdf:first impact_factor_wos
    119 rdf:rest rdf:nil
    120 N6fc64dee360b46cb87b589216e68955f schema:author N7372a1df58524751b4163a30908fbeae
    121 schema:dateCreated 2014
    122 schema:ratingValue 3.189
    123 rdf:type schema:Rating
    124 N71dd4105fe374871962e2a3ec6b2235a rdf:first impact_factor_wos
    125 rdf:rest rdf:nil
    126 N71ed2763f98942fd8f70d561f4d892ed rdf:first impact_factor_wos
    127 rdf:rest rdf:nil
    128 N7372a1df58524751b4163a30908fbeae rdf:first impact_factor_wos
    129 rdf:rest rdf:nil
    130 N7b92e298bbed42f380381c11796cddf7 schema:author N361871e603c04d299c0aba024811a640
    131 schema:dateCreated 2017
    132 schema:ratingValue 2.771
    133 rdf:type schema:Rating
    134 N877b899b7c0e4ad88e0a926cb3608bdf rdf:first sjr
    135 rdf:rest rdf:nil
    136 N8c51552e315142eab771f7c9de20fe14 schema:name lccn_id
    137 schema:value 89646567
    138 rdf:type schema:PropertyValue
    139 N8cca8e08f16f4a8da9446f6363aa7329 rdf:first impact_factor_wos
    140 rdf:rest rdf:nil
    141 N8dc78b5d1207437fa0549d642d44d633 rdf:first impact_factor_wos
    142 rdf:rest rdf:nil
    143 N963510edcf164bf495d64fc5b0a457dd schema:author N8cca8e08f16f4a8da9446f6363aa7329
    144 schema:dateCreated 2013
    145 schema:ratingValue 2.952
    146 rdf:type schema:Rating
    147 N9651b1385e554082ab3ae28749081f8b rdf:first impact_factor_wos
    148 rdf:rest rdf:nil
    149 N97b85860478b48c18cc20bbe197043eb rdf:first snip
    150 rdf:rest rdf:nil
    151 N9cbd216a61c54d12b140f2d030792e39 schema:author N877b899b7c0e4ad88e0a926cb3608bdf
    152 schema:ratingValue 1.349
    153 rdf:type schema:Rating
    154 N9d53a431086d4d66a515dbcb9e1f47bf rdf:first impact_factor_wos
    155 rdf:rest rdf:nil
    156 N9de36d08fd4141619dddb889ae4f40d8 rdf:first impact_factor_wos
    157 rdf:rest rdf:nil
    158 Na54cf57933ab4737800f5f3bd537f341 schema:author N6714ba7a4179429d9802072d976b6502
    159 schema:dateCreated 2014
    160 schema:ratingValue 3.189
    161 rdf:type schema:Rating
    162 Nac664664617242748f05a670ef17b8b0 schema:name springer_id
    163 schema:value 10557
    164 rdf:type schema:PropertyValue
    165 Nad6b482a7c8b4a4a90c3696b081abdaa schema:author N663d64830088467f909b3928c855b336
    166 schema:dateCreated 2010
    167 schema:ratingValue 3.098
    168 rdf:type schema:Rating
    169 Naf2096091a1e4b66a5286f81d7228547 schema:author N9de36d08fd4141619dddb889ae4f40d8
    170 schema:dateCreated 2015
    171 schema:ratingValue 3.189
    172 rdf:type schema:Rating
    173 Nb05be21926a94ce5ae77ebe726dfbe81 schema:author N5d61925e03a740b1aeecf5791d49e645
    174 schema:dateCreated 2010
    175 schema:ratingValue 3.098
    176 rdf:type schema:Rating
    177 Nc1a0e052e4374b798d8c6dcae47cbc8f schema:author N97b85860478b48c18cc20bbe197043eb
    178 schema:ratingValue 0.808
    179 rdf:type schema:Rating
    180 Nc9c57d4c8ae74902aa48415812384407 schema:familyName Remme
    181 schema:givenName Willem J.
    182 rdf:type schema:Person
    183 Nc9e24fa05114405c8474c1c0aa8df738 rdf:first Nc9c57d4c8ae74902aa48415812384407
    184 rdf:rest rdf:nil
    185 Ncaf68e302f724bc0823303f7d6f3d09b rdf:first impact_factor_wos
    186 rdf:rest rdf:nil
    187 Ncf82eb3a41e548c8bb98034f02fb1224 schema:author Nd8c9ee63ae4b40f7b93068dd34f3bd1a
    188 schema:dateCreated 2009
    189 schema:ratingValue 2.515
    190 rdf:type schema:Rating
    191 Nd8c9ee63ae4b40f7b93068dd34f3bd1a rdf:first impact_factor_wos
    192 rdf:rest rdf:nil
    193 sg:ontologies/product-market-codes/H33037 schema:inDefinedTermSet sg:ontologies/product-market-codes/
    194 schema:name Cardiology
    195 rdf:type schema:DefinedTerm
     




    Preview window. Press ESC to close (or click here)


    ...